Outcome with total therapy 3 (TT3) compared to total therapy 2 (TT2): Role of GEP70-defined high-risk disease with trisomy of 1q21 and activation of the proteasome gene PSMD4.

Abstract

8027 Background: A GEP-based risk model (GEP70) defines 15% of newly diagnosed MM with a median survival of 2yr compared to 10+yr others. GEP70 is driven by elevated expression of genes from chromo...